Patents by Inventor Claudia Kesch

Claudia Kesch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230042600
    Abstract: This invention provides compositions for controlled localized depositing of one or more drugs within a subject. More particularly, described herein are compositions comprising a) a polyethylene glycol (PEG) composition having a first low molecular weight PEG (Mw between 200-500 Da) and a second low molecular weight PEG (Mw between 500-2000 Da) and b) a mucoadhesive in polymer. Alternatively, composition may comprise a) a polyethylene glycol (PEG) composition having a first low molecular weight PEG (Mw between 200-500 Da) and a second low molecular weight PEG (Mw between 500-2000 Da), b) a water insoluble polymer and c) a mucoadhesive polymer. Furthermore, the composition may further comprise one or more drugs. Also provided are methods of manufacturing and administering the compositions described herein, which are used as biodegradable, injectable mucoadhesive low-viscosity pastes.
    Type: Application
    Filed: February 6, 2021
    Publication date: February 9, 2023
    Inventors: Veronika Schmitt, John K. Jackson, Martin E. Gleave, Claudia Kesch
  • Publication number: 20220152207
    Abstract: This invention provides compositions for controlled localized release of one or more drugs within a subject. More particularly, described herein are compositions comprising a hydrophobic water-insoluble polymer, a low molecular weight biocompatible glycol, and one or more drugs. The compositions described herein may also optionally include a di-block copolymer and/or a swelling agent.
    Type: Application
    Filed: October 8, 2021
    Publication date: May 19, 2022
    Inventors: John K. Jackson, Martin E. Gleave, Veronika Schmitt, Claudia Kesch
  • Patent number: 11167034
    Abstract: This invention provides compositions for controlled localized release of one or more drugs within a subject. More particularly, described herein are compositions comprising a hydrophobic water-insoluble polymer, a low molecular weight biocompatible glycol, and one or more drugs. The compositions described herein may also optionally include a di-block copolymer and/or a swelling agent.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: November 9, 2021
    Assignee: The University of British Columbia
    Inventors: John K. Jackson, Martin E. Gleave, Veronika Schmitt, Claudia Kesch
  • Publication number: 20200147223
    Abstract: This invention provides compositions for controlled localized release of one or more drugs within a subject. More particularly, described herein are compositions comprising a hydrophobic water-insoluble polymer, a low molecular weight biocompatible glycol, and one or more drugs. The compositions described herein may also optionally include a di-block copolymer and/or a swelling agent.
    Type: Application
    Filed: June 13, 2018
    Publication date: May 14, 2020
    Inventors: John K. Jackson, Martin E. Gleave, Veronika Schmitt, Claudia Kesch